Skip to main content
Retour
IMCR logo

Immunocore Holdings plc

Qualité des données : 100%
IMCR
NASDAQ Healthcare Biotechnology
29,95 €
▼ 0,41 € (-1,33%)
Cap. Boursière : 1,52B
Fourchette du Jour
29,18 € 30,31 €
Fourchette 52 Semaines
23,15 € 40,72 €
Volume
703 181
Moyenne 50J / 200J
32,61 € / 34,03 €
Clôture Précédente
30,35 €

Quick Summary

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Healthcare (627 pairs)

Métrique Action Médiane du Secteur
P/E -57,5 0,4
P/B 4,0 2,9
ROE % -7,1 3,9
Net Margin % -8,9 3,8
Rev Growth 5Y % 69,0 10,0
D/E 0,1 0,2

Objectif de Cours des Analystes

Hold
47,25 € +57.8%
Low: 36,00 € High: 60,00 €
BPA Prévisionnel
-0,96 €
CA Est.
448,80M

Estimations de Bénéfices

Période BPA Est. CA Est. Analystes
FY2030 6,20 €
5,10 € – 7,14 €
1,05B 3
FY2029 3,08 €
2,53 € – 3,55 €
809,77M 3
FY2028 -0,01 €
-0,05 € – 0,04 €
597,00M 9

Insider Trading Activity

Buy ratio (90d) 0.0%
20 transactions
Date Insider Type Shares Price Value
Feb 18, 2026
Berman David M
HEAD OF R&D
sell 5 965 32,35 € 192 967,75 €
Feb 18, 2026
St Leger Tina Amber
CHIEF HR OFFICER
sell 1 000 32,35 € 32 350,00 €
Feb 18, 2026
GOLL JOHN
SVP, FINANCE & CAO
sell 698 32,35 € 22 580,30 €
Feb 17, 2026
Berman David M
HEAD OF R&D
other 23 648
Feb 17, 2026
St Leger Tina Amber
CHIEF HR OFFICER
other 4 238
Feb 17, 2026
GOLL JOHN
SVP, FINANCE & CAO
other 2 702
Feb 17, 2026
GOLL JOHN
SVP, FINANCE & CAO
grant 28 663
Nov 28, 2025
Berman David M
HEAD OF R&D
other 11 042 17,46 €
Nov 28, 2025
Berman David M
HEAD OF R&D
sell 5 521 40,09 € 221 336,89 €
Nov 26, 2025
Berman David M
HEAD OF R&D
other 138 808 17,46 €
Nov 26, 2025
Berman David M
HEAD OF R&D
sell 69 404 40,12 € 2 784 488,48 €
Nov 24, 2025
Berman David M
HEAD OF R&D
other 100 17,46 € 1 746,00 €
Sep 11, 2025
Berman David M
HEAD OF R&D
other 38 162 17,46 €
Sep 11, 2025
Berman David M
HEAD OF R&D
sell 19 081 36,28 € 692 258,68 €
Sep 10, 2025
Berman David M
HEAD OF R&D
other 62 676 17,46 €
Sep 10, 2025
Berman David M
HEAD OF R&D
sell 31 338 36,12 € 1 132 708,56 €
Sep 5, 2025
Reback Mitch
CHIEF FINANCIAL OFFICER
other 280 316
Aug 18, 2025
Reback Mitch
CHIEF FINANCIAL OFFICER
sell 11 530 9,19 € 105 960,70 €
May 16, 2025
Reback Mitch
CHIEF FINANCIAL OFFICER
sell 10 088 15,23 € 153 640,24 €
May 15, 2025
Herbst Roy Steven
grant 26 198

Dividend History

Yield

0,00%

Payout Ratio

N/A

Growth (3Y)

N/A

Growth (5Y)

N/A

No dividend history available.

Points Clés

Revenue grew 68,99% annually over 5 years — strong growth
Debt/Equity of 0,11 — conservative balance sheet
Negative free cash flow of -11,20M
Revenue growth is decelerating — 1Y growth trails 5Y average by 48,89%
Capital efficient — spends only 1,08% of revenue on capex

Croissance

Revenue Growth (5Y)
68,99%
Revenue (1Y)20,10%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
-7,12%
ROIC-5,96%
Net Margin-8,88%
Op. Margin-11,34%

Sécurité

Debt / Equity
0,11
Current Ratio4,04
Interest Coverage-2,77

Valorisation

P/E Ratio
-57,46
Forward P/EN/A
P/B Ratio3,98
EV/EBITDAN/A
Dividend Yield0,00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 20,10% Revenue Growth (3Y) 9,22%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 68,99% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 297,57M Net Income (TTM) -26,42M
ROE -7,12% ROA -2,48%
Gross Margin 97,91% Operating Margin -11,34%
Net Margin -8,88% Free Cash Flow (TTM) -11,20M
ROIC -5,96% FCF Growth (3Y) N/A
Safety
Debt / Equity 0,11 Current Ratio 4,04
Interest Coverage -2,77
Dividends
Dividend Yield 0,00% Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -57,46 Forward P/E N/A
P/B Ratio 3,98 P/S Ratio 5,10
PEG Ratio 1,38 Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -0,74%
Market Cap 1,52B Enterprise Value 1,09B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 297,57M 247,77M 249,43M 144,23M 36,48M
Net Income -26,42M -40,81M -55,29M -43,46M -180,03M
EPS (Diluted) -0,53 -1,02 -1,13 -0,95 -3,00
Gross Profit 291,36M 239,38M 248,39M 138,94M 36,48M
Operating Income -33,74M -56,28M -59,65M -42,77M -174,59M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 1,07B 1,01B 597,00M 526,76M 407,28M
Total Liabilities 686,24M 648,79M 228,16M 187,86M 175,76M
Shareholders' Equity 381,03M 360,72M 368,84M 338,90M 231,53M
Total Debt 43,56M 432,72M 84,03M 81,45M 86,16M
Cash & Equivalents 467,71M 455,73M 442,63M 402,47M 321,06M
Current Assets 996,74M 929,86M 528,82M 473,98M 354,58M
Current Liabilities 246,70M 212,18M 139,02M 100,84M 82,57M

Scores de Stratégies

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Custom Full Throttle
#83 of 146
42

Activité Récente

Entré Full Throttle
Mar 24, 2026